Mainstream

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Post ContentzvraRead More

You might also be interested in reading Why Tokens Will Lead the Next Wave of Financial Innovation.

May 14, 2025
In Mainstream